Abingdon Health Plc
ABDXF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $19,839 | $16,909 | $16,581 | $16,759 |
| - Cash | $3,671 | $1,440 | $1,998 | $3,236 |
| + Debt | $1,009 | $1,049 | $1,008 | $1,019 |
| Enterprise Value | $17,177 | $16,518 | $15,591 | $14,542 |
| Revenue | $3,871 | $3,725 | $1,205 | $2,934 |
| % Growth | 3.9% | 209.1% | -58.9% | – |
| Gross Profit | $1,184 | $2,401 | -$212 | $1,444 |
| % Margin | 30.6% | 64.5% | -17.6% | 49.2% |
| EBITDA | -$1,964 | -$1 | -$447 | -$188 |
| % Margin | -50.7% | -0% | -37.1% | -6.4% |
| Net Income | -$3,154 | -$66 | -$1,205 | -$1,030 |
| % Margin | -81.5% | -1.8% | -100% | -35.1% |
| EPS Diluted | -0.007 | -0 | -0.002 | -0.003 |
| % Growth | -3,450% | 90% | 41.2% | – |
| Operating Cash Flow | -$2,685 | -$460 | -$1,173 | -$995 |
| Capital Expenditures | -$8 | -$17 | -$22 | -$99 |
| Free Cash Flow | -$2,692 | -$477 | -$1,195 | -$1,094 |